Lisata Therapeutics (LSTA) Earnings Analysis

Lisata Therapeutics (LSTA) next reports earnings on 2026-08-06. It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E -1.18.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does LSTA next report earnings?

Next earnings date2026-08-06
Consensus EPS estimaten/a
Revenue estimaten/a

LSTA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-0.5 USDn/an/an/a
2026-03-12-0.33 USD-0.51 USD+35.3%Beat
2025-11-06-0.49 USD-0.54 USD+9.3%Beat
2025-08-07-0.54 USD-0.65 USD+16.9%Beat
2025-02-27-0.55 USD-0.76 USD+27.6%Beat
2024-08-12-0.61 USD-0.75 USD+18.7%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

LSTA valuation and analyst view

Trailing P/E-1.18
Trailing EPS-1.81557 USD
Price / book1.81
Dividend yield0.00%
Market cap0.02B
Analyst consensusHold (0 buy / 2 hold / 0 sell)

Related research pages

Frequently asked questions

When is Lisata Therapeutics (LSTA)'s next earnings date?

Lisata Therapeutics is next scheduled to report on 2026-08-06.

Did LSTA beat earnings last quarter?

Consensus estimate data was not available for LSTA's 2026-05-11 report.

What is LSTA's earnings track record?

Over the last 5 reported quarters with consensus data, LSTA beat estimates 5 times (100%).

What is LSTA's current P/E ratio and EPS?

LSTA trades at a trailing P/E of -1.18 on trailing EPS of -1.8155673995114368 USD.

What do analysts rate LSTA?

Analyst consensus is "Hold" across 2 ratings (0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell).